Chemical formula: C₁₂H₁₀BiK₃O₁₄ Molecular mass: 780.654 g/mol PubChem compound: 118987133
Tripotassium dicitrato bismuthate interacts in the following cases:
It is recommended to avoid alcohol and carbonated drinks during the treatment. Milk (in coffee or tea) and antacids can be taken in small quantities, but never ½ hour before or after taking the tripartite bismuth bismuth. General fluid intake should also be avoided during this period.
Antacids and milk are recommended not to be taken at the same time, as it is possible to inhibit the action of tricalcium bisetrate.
There are insufficient data on the use of tripotassium dicitratobismuthate during pregnancy in humans to assess its potential harmful effects. To date, no indications of harmful effects have been found in animal tests.
Due to lack of data, use during pregnancy is not recommended.
There are insufficient data on the use of dicitratobismuthate during lactation in humans to assess its potential harmful effects.
There are no known data on the effect of this product on the ability to drive. However, an effect on the ability to drive or operate machinery is unlikely.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
